SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome

Jose F. Falantes,Francisco J. Márquez-Malaver,Estrella Carrillo-Cruz,Rosario M Morales-Camacho,Concepción Prats-Martín,Teresa Caballero,Eduardo Rodriguez Arbolí,Ildefonso Espigado,Jose A. Perez-Simon

Clinical lymphoma, myeloma & leukemia（2022）

引用 2|浏览7

暂无评分

摘要

Incorporation of molecular testing in LR-MDS identified a subset of patients with expected poorer outcome, either due to lower survival or probability of leukemic progression.

查看译文

关键词

Genetics,Leukemic progression,Myelodysplasia,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要